Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.






21st Austria weekly - AT&S, Vienna Stock Exchange, Polytec, Marinomed (04/10/2021)

10.10.2021

AT&S: Effective October 1, 2021 Philipp Gebhardt has taken over the position of “Director Investor Relations” at technology group AT&S. He succeeds Gerda Königstorfer, who will leave the company at her request. She will continue to work for AT&S until November 30, 2021, to ensure an orderly handover of all tasks. Born in Germany, Gebhardt studied economics at the Ludwig Maximilians University in Munich and obtained a CFA (Chartered Financial Analyst) degree. He has been working as a consultant and IR manager for international companies for more than 13 years and was most recently Director IR at Fresenius Medical Care in the USA and Germany.
AT&S: weekly performance: -6.91%

Vienna Stock Exchange: Trading participants generated equity turnover of Euro 54.96 bn on Wiener Börse (Vienna Stock Exchange) over the course of the year, an increase of 5.8% (Q1-Q3 2020: Euro 51.95 bn). At 84%, a large part originates from international exchange members. The average monthly turnover of Euro 6.1 bn is the highest level in ten years. The most actively traded equities year-to-date were Erste Group Bank AG (Euro 8.32 bn), OMV AG (Euro 7.97 bn), Verbund AG (Euro 6.20 bn), voestalpine AG (Euro 4.41 bn) and Raiffeisen Bank International AG (Euro 3.14 bn). With a turnover of Euro 691 mn, the strongest trading day in the third quarter was Friday, 17 September. Over the course of the year, the ATX Total Return (incl. dividends) gained 34.13%, stopping at 7,331.73 points on 30 September 2021 (ATX excl. dividends: 3,658.93 points, +31.60%). On 27 September 2021 it reached its all-time high of 7,406.96 points. This year, the Austrian national index is clearly outperforming other stock market barometers (CAC 40 +17.45 %, EUROSTOXX +14.48 %, DAX +11.24 %, FTSE 100 +9.69 %).
ATX TR: weekly performance: 1.00%

Polytec: Polytec Group, manufacturer of top-quality plastics solutions, has reassessed the risks regarding the development of the 2021 financial year. The continuation of extremely short-term, call-off cancellations by our customers is resulting in disproportionate production costs and simultaneous declines in sales. Moreover, the prospect held out by customers that the vehicle production losses incurred up to the summer would be made good in autumn is failing to materialise. At present, customers are unable to provide any reliable information on planned volumes for the remaining months, which means that an outlook would be based exclusively on our own estimates without taking into account customer model policies. Various negotiations are currently under way with customers regarding compensation for the additional expenses incurred, including the additional material costs, but these have yet to be concluded. In view of these considerable uncertainties, at the moment it is impossible to make a well-founded estimate of sales and result expectations. Nonetheless, the group management assumes that EBIT (earnings before interest and taxes) in the 2021 financial year will be clearly positive.
Polytec Group: weekly performance: -1.33%

Marinomed: Marinomed Biotech AG, an Austrian science-based biotech company with globally marketed therapeutics derived from innovative proprietary technology platforms, announces that it has secured financing in a total amount of up to Eur 5.4 mn via a flexible Convertible Notes Funding Program (CNFP) from the Swiss investment firm Nice & Green S.A. The flexible financing provided by this program enables Marinomed to advance its scientific and clinical programs for its two proprietary assets, the virus blocking Carragelose technology and the Marinosolv platform for the solubilization of pharmaceutical compounds. Under the terms of the agreement, Marinomed Biotech AG is entitled to issue up to 18 tranches of zero-coupon convertible bonds of up to Eur 300,000 per tranche during the contractual period of approximately 23 months. Nice & Green S.A. has committed to subscribe for those convertible notes and shall request the conversion into ordinary shares of the Company within a specific period after their issuance.
Marinomed Biotech: weekly performance: -6.52%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (04/10/2021)


Partners









latest 21st Austria

21st Austria weekly - AT&S, Vienna Stock Exchange, Polytec, Marinomed (04/10/2021)


10.10.2021, 4212 Zeichen



AT&S: Effective October 1, 2021 Philipp Gebhardt has taken over the position of “Director Investor Relations” at technology group AT&S. He succeeds Gerda Königstorfer, who will leave the company at her request. She will continue to work for AT&S until November 30, 2021, to ensure an orderly handover of all tasks. Born in Germany, Gebhardt studied economics at the Ludwig Maximilians University in Munich and obtained a CFA (Chartered Financial Analyst) degree. He has been working as a consultant and IR manager for international companies for more than 13 years and was most recently Director IR at Fresenius Medical Care in the USA and Germany.
AT&S: weekly performance: -6.91%

Vienna Stock Exchange: Trading participants generated equity turnover of Euro 54.96 bn on Wiener Börse (Vienna Stock Exchange) over the course of the year, an increase of 5.8% (Q1-Q3 2020: Euro 51.95 bn). At 84%, a large part originates from international exchange members. The average monthly turnover of Euro 6.1 bn is the highest level in ten years. The most actively traded equities year-to-date were Erste Group Bank AG (Euro 8.32 bn), OMV AG (Euro 7.97 bn), Verbund AG (Euro 6.20 bn), voestalpine AG (Euro 4.41 bn) and Raiffeisen Bank International AG (Euro 3.14 bn). With a turnover of Euro 691 mn, the strongest trading day in the third quarter was Friday, 17 September. Over the course of the year, the ATX Total Return (incl. dividends) gained 34.13%, stopping at 7,331.73 points on 30 September 2021 (ATX excl. dividends: 3,658.93 points, +31.60%). On 27 September 2021 it reached its all-time high of 7,406.96 points. This year, the Austrian national index is clearly outperforming other stock market barometers (CAC 40 +17.45 %, EUROSTOXX +14.48 %, DAX +11.24 %, FTSE 100 +9.69 %).
ATX TR: weekly performance: 1.00%

Polytec: Polytec Group, manufacturer of top-quality plastics solutions, has reassessed the risks regarding the development of the 2021 financial year. The continuation of extremely short-term, call-off cancellations by our customers is resulting in disproportionate production costs and simultaneous declines in sales. Moreover, the prospect held out by customers that the vehicle production losses incurred up to the summer would be made good in autumn is failing to materialise. At present, customers are unable to provide any reliable information on planned volumes for the remaining months, which means that an outlook would be based exclusively on our own estimates without taking into account customer model policies. Various negotiations are currently under way with customers regarding compensation for the additional expenses incurred, including the additional material costs, but these have yet to be concluded. In view of these considerable uncertainties, at the moment it is impossible to make a well-founded estimate of sales and result expectations. Nonetheless, the group management assumes that EBIT (earnings before interest and taxes) in the 2021 financial year will be clearly positive.
Polytec Group: weekly performance: -1.33%

Marinomed: Marinomed Biotech AG, an Austrian science-based biotech company with globally marketed therapeutics derived from innovative proprietary technology platforms, announces that it has secured financing in a total amount of up to Eur 5.4 mn via a flexible Convertible Notes Funding Program (CNFP) from the Swiss investment firm Nice & Green S.A. The flexible financing provided by this program enables Marinomed to advance its scientific and clinical programs for its two proprietary assets, the virus blocking Carragelose technology and the Marinosolv platform for the solubilization of pharmaceutical compounds. Under the terms of the agreement, Marinomed Biotech AG is entitled to issue up to 18 tranches of zero-coupon convertible bonds of up to Eur 300,000 per tranche during the contractual period of approximately 23 months. Nice & Green S.A. has committed to subscribe for those convertible notes and shall request the conversion into ordinary shares of the Company within a specific period after their issuance.
Marinomed Biotech: weekly performance: -6.52%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (04/10/2021)



BSN Podcasts
Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #637: Egalite Addiko und Marinomed, AT&S nach 2 Monaten zurück, 19 Jahre RBI an der Börse, Strabag top




 

Bildnachweis

Aktien auf dem Radar:Addiko Bank, Immofinanz, Marinomed Biotech, Flughafen Wien, Warimpex, EuroTeleSites AG, ATX Prime, ams-Osram, AT&S, Palfinger, RBI, Strabag, Pierer Mobility, UBM, CA Immo, Frequentis, Lenzing, SW Umwelttechnik, Oberbank AG Stamm, Wolford, Agrana, Amag, Erste Group, EVN, Kapsch TrafficCom, OMV, Österreichische Post, Telekom Austria, Uniqa, VIG, Wienerberger.


Random Partner

VAS AG
Die VAS AG ist ein Komplettanbieter für feststoffbefeuerte Anlagen zur Erzeugung von Wärme und Strom mit über 30-jähriger Erfahrung. Wir planen, bauen und warten Anlagen im Bereich von 2 bis 30 MW für private, industrielle und öffentliche Kunden in ganz Europa. Wir entwickeln maßgefertigte Projekte ganz nach den Bedürfnissen unserer Kunden durch innovative Lösungen.

>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner


Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten